557 related articles for article (PubMed ID: 27821816)
21. Sirt6 stabilizes atherosclerosis plaques by promoting macrophage autophagy and reducing contact with endothelial cells.
Wang T; Sun C; Hu L; Gao E; Li C; Wang H; Sun D
Biochem Cell Biol; 2020 Apr; 98(2):120-129. PubMed ID: 31063699
[TBL] [Abstract][Full Text] [Related]
22. MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALL.
Poole CJ; Lodh A; Choi JH; van Riggelen J
Epigenetics Chromatin; 2019 Jul; 12(1):41. PubMed ID: 31266538
[TBL] [Abstract][Full Text] [Related]
23. Coiled-coil domain-containing 80 accelerates atherosclerosis development through decreasing lipoprotein lipase expression via ERK1/2 phosphorylation and TET2 expression.
Gong D; Zhang Q; Chen LY; Yu XH; Wang G; Zou J; Zheng XL; Zhang DW; Yin WD; Tang CK
Eur J Pharmacol; 2019 Jan; 843():177-189. PubMed ID: 30439364
[TBL] [Abstract][Full Text] [Related]
24. New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4/NF-κB pathway.
Tang ZH; Peng J; Ren Z; Yang J; Li TT; Li TH; Wang Z; Wei DH; Liu LS; Zheng XL; Jiang ZS
Atherosclerosis; 2017 Jul; 262():113-122. PubMed ID: 28535426
[TBL] [Abstract][Full Text] [Related]
25. SOAT1 deficiency attenuates atherosclerosis by regulating inflammation and cholesterol transportation via HO-1 pathway.
Wu N; Li RQ; Li L
Biochem Biophys Res Commun; 2018 Jun; 501(2):343-350. PubMed ID: 29567472
[TBL] [Abstract][Full Text] [Related]
26. Oxidized low-density lipoprotein inhibits THP-1-derived macrophage autophagy via TET2 down-regulation.
Li G; Peng J; Liu Y; Li X; Yang Q; Li Y; Tang Z; Wang Z; Jiang Z; Wei D
Lipids; 2015 Feb; 50(2):177-83. PubMed ID: 25503193
[TBL] [Abstract][Full Text] [Related]
27. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P
Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724
[TBL] [Abstract][Full Text] [Related]
28. TET2-Mediated Spatiotemporal Changes of 5-Hydroxymethylcytosine During Organogenesis in the Late Mouse Fetus.
Li X; Xie F; Jin J; Wu Y; Luo Z; Zhang F; Zhang S; Chen D; Liu A
Anat Rec (Hoboken); 2019 Jun; 302(6):954-963. PubMed ID: 30369084
[TBL] [Abstract][Full Text] [Related]
29. Deletion of the angiotensin II type 1a receptor prevents atherosclerotic plaque rupture in apolipoprotein E-/- mice.
Aono J; Suzuki J; Iwai M; Horiuchi M; Nagai T; Nishimura K; Inoue K; Ogimoto A; Okayama H; Higaki J
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1453-9. PubMed ID: 22460554
[TBL] [Abstract][Full Text] [Related]
30. Myricitrin attenuates endothelial cell apoptosis to prevent atherosclerosis: An insight into PI3K/Akt activation and STAT3 signaling pathways.
Qin M; Luo Y; Meng XB; Wang M; Wang HW; Song SY; Ye JX; Pan RL; Yao F; Wu P; Sun GB; Sun XB
Vascul Pharmacol; 2015 Jul; 70():23-34. PubMed ID: 25849952
[TBL] [Abstract][Full Text] [Related]
31. Prolyl hydroxylase 3 overexpression accelerates the progression of atherosclerosis in ApoE-/- mice.
Liu H; Xia Y; Li B; Pan J; Lv M; Wang X; An F
Biochem Biophys Res Commun; 2016 Apr; 473(1):99-106. PubMed ID: 26995088
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-27 Prevents Atherosclerosis by Suppressing Lipoprotein Lipase-Induced Lipid Accumulation and Inflammatory Response in Apolipoprotein E Knockout Mice.
Xie W; Li L; Zhang M; Cheng HP; Gong D; Lv YC; Yao F; He PP; Ouyang XP; Lan G; Liu D; Zhao ZW; Tan YL; Zheng XL; Yin WD; Tang CK
PLoS One; 2016; 11(6):e0157085. PubMed ID: 27257686
[TBL] [Abstract][Full Text] [Related]
33. Pim-2 kinase inhibits inflammation by suppressing the mTORC1 pathway in atherosclerosis.
Liao M; Hu F; Qiu Z; Li J; Huang C; Xu Y; Cheng X
Aging (Albany NY); 2021 Sep; 13(18):22412-22431. PubMed ID: 34547720
[TBL] [Abstract][Full Text] [Related]
34. The feedback loop of "EMMPRIN/NF-κB" worsens atherosclerotic plaque via suppressing autophagy in macrophage.
Liang X; Hou X; Yang Y; Liu H; Guo R; Yang Z; Yang L
J Mol Cell Cardiol; 2018 Jan; 114():129-140. PubMed ID: 29154780
[TBL] [Abstract][Full Text] [Related]
35. Insulin inhibits inflammation and promotes atherosclerotic plaque stability via PI3K-Akt pathway activation.
Yan H; Ma Y; Li Y; Zheng X; Lv P; Zhang Y; Li J; Ma M; Zhang L; Li C; Zhang R; Gao F; Wang H; Tao L
Immunol Lett; 2016 Feb; 170():7-14. PubMed ID: 26681144
[TBL] [Abstract][Full Text] [Related]
36. OxLDL induces vascular endothelial cell pyroptosis through miR-125a-5p/TET2 pathway.
Zhaolin Z; Jiaojiao C; Peng W; Yami L; Tingting Z; Jun T; Shiyuan W; Jinyan X; Dangheng W; Zhisheng J; Zuo W
J Cell Physiol; 2019 May; 234(5):7475-7491. PubMed ID: 30370524
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-200a Inhibits Inflammation and Atherosclerotic Lesion Formation by Disrupting EZH2-Mediated Methylation of STAT3.
Wang J; Li P; Xu X; Zhang B; Zhang J
Front Immunol; 2020; 11():907. PubMed ID: 32655542
[TBL] [Abstract][Full Text] [Related]
38. Neopterin Counters Vascular Inflammation and Atherosclerosis.
Shirai R; Sato K; Yamashita T; Yamaguchi M; Okano T; Watanabe-Kominato K; Watanabe R; Matsuyama TA; Ishibashi-Ueda H; Koba S; Kobayashi Y; Hirano T; Watanabe T
J Am Heart Assoc; 2018 Feb; 7(3):. PubMed ID: 29420219
[TBL] [Abstract][Full Text] [Related]
39. Hsa_circ_0030042 regulates abnormal autophagy and protects atherosclerotic plaque stability by targeting eIF4A3.
Yu F; Zhang Y; Wang Z; Gong W; Zhang C
Theranostics; 2021; 11(11):5404-5417. PubMed ID: 33859754
[No Abstract] [Full Text] [Related]
40. Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression.
Horio E; Kadomatsu T; Miyata K; Arai Y; Hosokawa K; Doi Y; Ninomiya T; Horiguchi H; Endo M; Tabata M; Tazume H; Tian Z; Takahashi O; Terada K; Takeya M; Hao H; Hirose N; Minami T; Suda T; Kiyohara Y; Ogawa H; Kaikita K; Oike Y
Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):790-800. PubMed ID: 24526691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
